Lu-177-PSMA-617 Radionuclide Therapy (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

Lu-177-PSMA-617 Radionuclide Therapy

Caption

Lu-177-PSMA-617 radionuclide therapy can reduce tumor burden and induce PSA remission in patients with metastatic advanced prostate cancer.

Credit

Kambiz Rahbar, M.D., Department of Nuclear Medicine, University Hospital Muenster, and Wolfgang Peter Fendler, M.D., Department of Nuclear Medicine, University Hospital Munich

Usage Restrictions

Use with caption and credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.